EuniceLKwakMDPhD

Clinical Trials

• Phase 2 Study of Oral MKC-1 in Patients With Unresectable or Metastatic Pancreatic Cancer Start of enrollment: 2007 Nov 01

  Completed

  Phase 2

• Temsirolimus in Combination With Gemcitabine in Previously Untreated Metastatic Pancreatic Cancer Start of enrollment: 2007 Oct 01

  Terminated

  Phase 1

• Temsirolimus (CCI-770, Torisel) Combined With Cetuximab in Cetuximab-Refractory Colorectal Cancer Start of enrollment: 2007 Nov 01

  Completed

  Phase 1

• A Trial of ALB 109564(a) in Subjects With Advanced Solid Tumors Start of enrollment: 2008 Sep 01

  Terminated

  Phase 1

• A Study of ARRY-438162 (MEK162) in Patients With Advanced Cancer Start of enrollment: 2009 Aug 01

  Completed

  Phase 1

• Safety Study of PLX108-01 in Patients With Solid Tumors Start of enrollment: 2009 Oct 01

  Completed

  Phase 1

• STA-9090 in Previously Treated Patients With Advanced Esophagogastric Cancer Start of enrollment: 2010 Aug 01

  Completed

  Phase 2

• CAPOX, Bevacizumab and Trastuzumab for Patients With HER2-Positive Metastatic Esophagogastric Cancer Start of enrollment: 2011 Feb 01

  Active, not recruiting

  Phase 2

• LDE225 With Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan for Untreated Advanced Pancreatic Cancer Start of enrollment: 2011 Dec 01

  Completed

  Phase 1

• FOLFOX +/- Ziv-Aflibercept for Esophageal and Gastric Cancer Start of enrollment: 2013 Jan 01

  Completed

  Phase 2

• Safety and Efficacy Study of PRI-724 Plus Gemcitabine in Subjects With Advanced or Metastatic Pancreatic Adenocarcinoma Start of enrollment: 2013 Apr 01

  Completed

  Phase 1

• A Study of Nivolumab Alone or Nivolumab Combination Therapy in Colon Cancer That Has Come Back or Has Spread Start of enrollment: 2014 Mar 12

  Active, not recruiting

  Phase 2

• Join now to see all